Perspectives of targeted mass spectrometry for protein biomarker verification

Abstract

SummaryThe identification of specific biomarkers will improve the early diagnosis of disease, facilitate the development of targeted therapies, and provide an accurate method to monitor treatment response. A major challenge in the process of verifying biomarker candidates in blood plasma is the complexity and high dynamic range of proteins. This article reviews the current, targeted proteomic strategies that are capable of quantifying biomarker candidates at concentration ranges where biomarkers are expected in plasma (i.e. at the ng/ml level). In addition, a workflow is presented that allows the fast and definitive generation of targeted mass spectrometry-based assays for most biomarker candidate proteins. These assays are stored in publicly accessible databases and have the potential to greatly impact the throughput of biomarker verification studies.

Accurate Quantification of Cardiovascular Biomarkers in Serum Using Protein Standard Absolute Quantification (PSAQ™) and Selected Reaction Monitoring

“…Selected Reaction Monitoring (SRM) 1 mass spectrometry combined with stable isotope dilution (SID-SRM) has shown promise as a solution to this technological hurdle (4,5). MS analysis in SRM mode offers the unique possibility to specifically and simultaneously monitor the signatures of hundreds of target peptides generated by trypsin digestion of proteins.…”

Both Targeted Mass Spectrometry and Flow Sorting Analysis Methods Detected the Decreased Serum Apolipoprotein E Level in Alzheimer's Disease Patients

“…For instance, the binding of a target protein to its binding partner has a better chance of preventing the binding of a target protein to an antibody, resulting in a lower concentration according to antibody detection. It is now widely accepted that SRM quantification for tryptic peptides provides relatively higher concentrations than antibody-based protein quantification in most experiments, and this high sensitivity of SRM analysis enables the quantification of lowabundance proteins in plasma (63). The various binding statuses of serum ApoE to ApoE receptors or binding partners may affect the binding affinity to a detection antibody, which needs to be further clarified for better understanding of the serum ApoE level.…”

Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics

“…Requirements for method validation (e.g., specificity, selectivity, assay acceptance criteria, stability, and reproducibility) and the utility of protein biomarkers have been reviewed by Lee (70). Targeted proteomic strategies have been applied to quantify biomarker candidates at concentrations of nanograms per milliliter or picograms per milliliter by LC-MS (71).…”